| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/23/2008 | CN101108001A Food with healthcare function |
| 01/23/2008 | CN101107997A Formula of fig antineoplastic oral liquid and technique for machining the same |
| 01/23/2008 | CN100363367C Compound with antitumor activity, and its preparing method and use |
| 01/23/2008 | CN100363366C Camptothecin derviative and preparation process thereof |
| 01/23/2008 | CN100363347C 4-(1-(sulfonyl)-1H-indol-2-yl)-4-(hydroxy)-cyclohexa-2,5-dienone compounds and analogs thereof as therapeutic agents |
| 01/23/2008 | CN100363057C Use of melanoma differentiation associated gene (mda-7) for reversing cancerous phenotype |
| 01/23/2008 | CN100363054C Cancer therapy using whole glucan particles and antibodies |
| 01/23/2008 | CN100363053C Intracellular isoform of the interleukin-1 receptor antagonist |
| 01/23/2008 | CN100363009C Microcapsule for preventing and curing tumour and production method thereof |
| 01/23/2008 | CN100363004C Use of the quinazoline derivative zd6474 combined with gemcitabine and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability |
| 01/23/2008 | CN100362995C CYP2A enzymes and their use in therapeutic and diagnostic method |
| 01/23/2008 | CN100362984C Prepn. method of matrine magnetic micro-ball |
| 01/22/2008 | US7321027 Mercaptan containing diagnostic agents for imaging malignant melanoma and distant metastases and rhenium (186Re, 188Re) therapeutic complexes for treating the same |
| 01/22/2008 | US7321026 Framework-patched immunoglobulins |
| 01/22/2008 | US7320996 Administering to a cancer patient an indole-2-one derivative containing pyrrole ring as protein kinase inhibitor together with a cyclooxygenase inhibitor to treat the cancer |
| 01/22/2008 | US7320995 Lung melanoma metastasis, rheumatoid arthritis, 1-isopropylsulfonyl-2-amino-6-(2-(2,6-difluorophenyl)-5-(phenyl)-imidazol-4-yl)-benzimidazole |
| 01/22/2008 | US7320993 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic useful as cytostatic and immuosuppressive agents |
| 01/22/2008 | US7320992 Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of use |
| 01/22/2008 | US7320991 Analogs of thalidomide as potential angiogenesis inhibitors |
| 01/22/2008 | US7320982 Use of 4-substituted tetrahydropyridines for the manufacture of medicaments acting upon TGF-β 1 |
| 01/22/2008 | US7320981 Variolin derivatives as anti-cancer agents |
| 01/22/2008 | US7320971 Cardenolide glycosides, which have a cytotoxic activity, cancer |
| 01/22/2008 | US7320963 Methods and compositions for delivery of pharmaceutical agents |
| 01/22/2008 | US7320863 Thyroid sodium/iodide symporter and nucleic acid encoding same |
| 01/22/2008 | US7320793 Comprises ordered and repetitive antigen or antigenic determinant array for developing vaccines for treatment of infectious diseases, allergies and cancer; microarrays |
| 01/22/2008 | US7320789 Antibody inhibitors of GDF-8 and uses thereof |
| 01/22/2008 | US7320786 Administering lyposomes of photosensitive receptors or ligands targeted to specific tissues, exposure to light causing destruction of bound tissues; treatment of eye neovascular disease due to macular degeneration, diabetes |
| 01/22/2008 | US7320785 Compositions and methods for modulation of DARPP-32 phosphorylation |
| 01/22/2008 | US7320784 Metal support surface, conjugate releasably bound to the support surface, the conjugate comprising a ligand and a targeting molecule;wherein the conjugate coordinates with a complex-forming metal ion so that labeled conjugate is released; radiotherapy and as imaging agents in medical diagnostics |
| 01/22/2008 | CA2495967C New synthesis process and new crystalline form for agomelatine, and pharmaceutical compositions containing it |
| 01/22/2008 | CA2431515C Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition, and use thereof |
| 01/22/2008 | CA2420999C 2-substituted heterocyclic compounds and their use in treating multidrug resistance |
| 01/22/2008 | CA2392168C Vitamin d analogues |
| 01/22/2008 | CA2374247C Heterocyclic derivatives useful as anticancer agents |
| 01/22/2008 | CA2293553C Aminooxyamide tricyclic inhibitors of farnesyl-protein transferase |
| 01/22/2008 | CA2289914C Igf-1 receptor interacting proteins (iips), genes coding therefor and uses thereof |
| 01/22/2008 | CA2281721C Phthalazines with angiogenesis inhibiting activity |
| 01/22/2008 | CA2214321C Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 01/17/2008 | WO2008008981A1 Interleukin 21 and tyrosine kinase inhibitor combination therapy |
| 01/17/2008 | WO2008008954A2 Isothiocyanates and glucosinolate compounds and anti-tumor compositios containing same |
| 01/17/2008 | WO2008008747A1 [4,5']bipyrimidinyl-6,4'-diamine derivatives as protein kinase inhbitors |
| 01/17/2008 | WO2008008549A2 Combination of an immunosuppressive agent and nonsteroidal anti -inflammatory drugs to treat neoplasia |
| 01/17/2008 | WO2008008539A2 Fused heterocyclic derivatives useful as inhibitors of the hepatocyte growth factor receptor |
| 01/17/2008 | WO2008008493A2 Alkyne-substituted pyridone compounds and methods of use |
| 01/17/2008 | WO2008008442A1 Preparation and utility of hmg-coa reductase inhibitors |
| 01/17/2008 | WO2008008432A2 Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods |
| 01/17/2008 | WO2008007999A1 Anti-tumoral, antibacterial and antiviral pharmaceutical composition (variants) |
| 01/17/2008 | WO2008007979A1 (2,6-dioxo-3-piperinyl)amidobenzoic immunomodulatory and anti-cancer derivatives |
| 01/17/2008 | WO2008007804A1 ANTIHUMAN α9 INTEGRIN ANTIBODY AND USE OF THE SAME |
| 01/17/2008 | WO2008007755A1 Cell death inducer |
| 01/17/2008 | WO2008007711A1 Sart3-derived peptide useful in cancer vaccine therapy for hla-a3 supertype allele-positive prostate cancer patient |
| 01/17/2008 | WO2008007450A1 Food, drink and medicinal composition having antitumor effect |
| 01/17/2008 | WO2008007367A1 Combination methods of treating cancer |
| 01/17/2008 | WO2008007290A2 Core-shell nanoparticles for thearapy and imaging purposes |
| 01/17/2008 | WO2008007123A2 Pharmaceutical compounds |
| 01/17/2008 | WO2008007114A1 Tetrahydrofuro [3, 2 -b] pyrr0l-3-ones as cathepsin k inhibitors |
| 01/17/2008 | WO2008007113A2 Pharmaceutical combinations |
| 01/17/2008 | WO2008007112A1 Tetrahydrofuro [3, 2-b] pyrr0l-3-ones as cathepsin k inhibitors |
| 01/17/2008 | WO2008007103A1 Furo [3, 2-b] pyrrol derivatives |
| 01/17/2008 | WO2008006974A2 Use of histamine h4 receptor ligands to protect haematopoietic progenitors against the haematological toxicity of chemotherapeutic agents |
| 01/17/2008 | WO2008006895A2 Methods and compositions for increasing the efficiency of therapeutic antibodies using gamma delta t cell activators |
| 01/17/2008 | WO2008006663A1 2-arylindole derivatives as npges-i inhibitors |
| 01/17/2008 | WO2008006626A1 Triphenyl modified 5-membered heterocycles and their use as anticancer and antiinflammatory agents |
| 01/17/2008 | WO2008006561A1 Substituted isoxalines, pharmaceutical compositions containing same, methods of preparing same, and uses of same |
| 01/17/2008 | WO2008006560A1 Substituted sulphoximines as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 01/17/2008 | WO2008006511A2 Use of fosfluridine tidoxil (ft) for the treatment of intraepithelial proliferative diseases |
| 01/17/2008 | WO2008006287A1 Inreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof |
| 01/17/2008 | WO2008006187A2 Protein complexes for prevention and treatment of diseases with angiogenesis disorders |
| 01/17/2008 | WO2008006168A1 Treatment of excessive neovascularization |
| 01/17/2008 | WO2007120669A8 Tetrahalogenated compounds useful as inhibitors of angiogenesis |
| 01/17/2008 | WO2007117577A3 High affinity human antibodies to human il-18 receptor |
| 01/17/2008 | WO2007101873A3 Betulonic acid esters and betulinic acid polyalkylene-glycol derivatives for the treatment of viral infection and cancer |
| 01/17/2008 | WO2007086093A3 Inhibitors of cell migration mediated by h-prune-gsk-3 complex and uses in antitumoral therapy |
| 01/17/2008 | WO2007084853A3 Methods for inhibiting osteoclastogenesis |
| 01/17/2008 | WO2007066187A3 Method of treating abnormal cell growth |
| 01/17/2008 | WO2007062150A3 Leukotoxin compositions and therapeutic methods |
| 01/17/2008 | WO2006137789A8 Quinoline 3 -sulfonate esters as NK3 receptor modulators |
| 01/17/2008 | WO2006060809A9 Methods of using [3.2.0] heterocyclic compounds and analogs thereof |
| 01/17/2008 | WO2004106938A3 Diagnostics and therapeutics for diseases associated with g protein-coupled p2y purinoreceptor 7 (p2y7) |
| 01/17/2008 | WO2004106935A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 103 (gpr103) |
| 01/17/2008 | WO2004072257A3 Dyrks as modifiers of the apc and axin pathways and methods of use |
| 01/17/2008 | WO2003004615A3 Secreted proteins |
| 01/17/2008 | US20080015252 Therapeutic agent for virus-associated malignancy |
| 01/17/2008 | US20080015249 Cancer treatment compositions and method using natural plant essential oils |
| 01/17/2008 | US20080015248 synthetic tea derived flavonoids, used for the of treatment of cancers; anticarcinogenic agents; enzyme inhibitors |
| 01/17/2008 | US20080015234 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 01/17/2008 | US20080015216 Histone Deacetylase Inhibitors |
| 01/17/2008 | US20080015212 Inhibitors Of Akt Activity |
| 01/17/2008 | US20080015207 administering a therapeutic amount of DL3 (6-amino-2-(2-4-tert-butyl-phenoxy)-ethylsulfanyl)-1H-pyrimidin-4-one) to a patient for treating prostate cancer, benign prostatic hyperplasia, hair loss |
| 01/17/2008 | US20080015206 Anti-cancer cyclopenta[G]quinazoline compounds |
| 01/17/2008 | US20080015205 Cancer Combination Therapy Comprising Azd2171 and Imatinib |
| 01/17/2008 | US20080015204 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 01/17/2008 | US20080015193 Certain azoles exhibiting ATP-utilizing enzyme inhibitory activity, compositions, and uses thereof |
| 01/17/2008 | US20080015192 Inhibitors of polo-like kinases |
| 01/17/2008 | US20080015191 Pyrazines and Pyridines and Derivatives Thereof as Therapeutic Compounds |
| 01/17/2008 | US20080015190 Inhibitors of Histone Deacetylase |
| 01/17/2008 | US20080015185 N-heterocyclic inhibitors of tnf-alpha expression |
| 01/17/2008 | US20080015184 Urea Substituted Imidazopyridines, Imidazoquinolines, and Imidazonaphthyridines |
| 01/17/2008 | US20080015183 Substituted quinazolin-4-ylamine analogues |
| 01/17/2008 | US20080015182 Potent PARP Inhibitors |